Oncology Imaging Guidelines

Diagnostic oncology imaging (primarily conventional modalities such as CT, MRI and bone scan) for evaluation, staging and surveillance of a wide range of cancers—including CNS, head and neck, skin/melanoma, thyroid, lung (SCLC/NSCLC), breast, GI/pancreatic, colorectal, renal/GU, sarcomas, neuroendocrine/adrenal tumors and many others. Major limitations/requirements: the tool addresses common symptom complexes so atypical presentations require physician review or specialist/PCP consultation; age-based guideline selection (adult ≥18 vs pediatric <18, with AYA 15–39 exceptions) applies; advanced imaging is generally limited (often one initial staging study when starting standard therapy), should be targeted rather than routine whole‑body screening, requires a recent clinical evaluation (within 60 days), and contrast use is restricted by allergy and renal function (eGFR <30 contraindicates GBCA).

"Splenic metastases"